How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...
The life-saving antiretroviral (ARV) medication can be made available in the next three years to the entire 14,000 HIV-infected Jamaicans who need it, given Jamaica's progress in responding to the disease, according to UNAIDS Country Co-ordinator Dr Pierre Somse.
Statistics indicate that 14,000 of the estimated 31,000 HIV-infected persons in Jamaica need to be on the drug, however there is not enough medication for some 7,000 persons.
But an optimistic Somse said Jamaica is in good standing to make the drug available to all who need it by 2015 as the country already provides the medication to more than 50 per cent of those who need to be on treatment.
Globally, only 42 per cent of those who need to be on treatment have access to the medication, while regionally ARVs are available to only 43 per cent of those who need them.
"We can achieve 100 per cent ARV therapy by 2015, because more than 50 per cent of those who need to be on the treatment are already on it, and so it's not like some countries where 100,000 of who need treatment don't have it," Somse said.
The UNAIDS head, who along with colleagues from other United Nations agencies addressed this week's Jamaica Observer Monday Exchange at the newspaper's head office in Kingston, said Jamaica is also on track to halting and reversing the trend of the epidemic by 2015, as it is among the countries which have since reduced the epidemic by 25 per cent.
"The perspective is bright, first because we have a small epidemic and so the size can be controlled since it's not like South Africa or elsewhere," Somse said.
This, he said, is unlike his native country, the Democratic Republic of Congo, where two million people are infected with HIV and only eight per cent of those who need treatment are on it.
"You come from this mountain of epidemic to a country where you have only 31,000 people living with HIV and only 14,000 need treatment... with will and the power the HIV programme Jamaica has can cover these people," he said.
Additionally, he said, Jamaica has had outstanding achievement in fighting the disease as it is among the first 21 countries, in 2010, to have greater than 80 per cent coverage of HIV-infected pregnant women.
"This has increased so far, Jamaica's ambition is to eliminate mother-to-child transmission (of HIV) by 2015," he said.
He noted, however, that the major issue the country faces in its response to the disease is that of human rights, legal barriers, and gender inequalities, all of which "drive the response and fuel the epidemic".
"With a holistic approach based on respect of human rights promotion, gender inequality, and focus on young people you can also reduce new HIV infections," Somse said.
However, he dismissed claims that too much of the funds designated for the fight against HIV have been directed to administrative and policy costs with very little going to a lot of the persons who are directly impacted by the disease.
Somse said Jamaica has done very well in its management and use of HIV funds, as investing in policy is not a second class intervention.
"You need the policy to allow intervention to work. Having commodities is not enough," he insisted.
Somse said the fact that HIV prevalence among men who have sex with men remains at 32 per cent is reflective of the policy constraint difficulties which make the HIV programme inaccessible to some of those who need to be reached the most.
He argued further that the HIV cases for girls age 10-19 are three times greater than for boys of the same age, and this reflects the vulnerability of girls.
"This reflects the policy environment which does not allow access to services to adolescents that are having sexual needs and the problem of age of consent," he said.
Policy issue today, he said, is a priority that UNAIDS is focusing on.
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.